semaglutide and cardiovascular outcomes in obesity without diabetes journal club Population‐level impact of semaglutide semaglutide and cardiovascular outcomes in

Noninvasive vagus nerve stimulators (different from the implantable kind used for epilepsy) send tiny electrical impulses to the vagus nerve, aiming to improve mood, sleep, and stress resilienceessentially, biohacking calm

Finally, more recent and therefore more speculative investigations have looked at the ability of GLP-1 to reduce the risk of neurodegenerative diseases

Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials

As of May 2025, over 1,800 Ozempic lawsuits have been filed

The Faster Research Protocol Some research protocols use a more compressed timeline, starting at a higher dose or spending only two to three weeks at each escalation step

This distinction exists even though obesity is recognized as a chronic disease by the American Medical Association and the Centers for Disease Control and Prevention